Boothbay Fund Management’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q4
Sell
-69,911
Closed -$8.09M 1940
2023
Q3
$8.09M Buy
69,911
+66,551
+1,981% +$7.7M 0.19% 73
2023
Q2
$346K Sell
3,360
-81,915
-96% -$8.42M 0.01% 1055
2023
Q1
$9.31M Sell
85,275
-6,967
-8% -$760K 0.19% 72
2022
Q4
$10.5M Buy
92,242
+9,854
+12% +$1.12M 0.24% 37
2022
Q3
$5.1M Buy
82,388
+14,701
+22% +$910K 0.13% 156
2022
Q2
$5.4M Buy
67,687
+5,356
+9% +$427K 0.14% 136
2022
Q1
$6.56M Buy
62,331
+14,608
+31% +$1.54M 0.15% 102
2021
Q4
$5.14M Buy
47,723
+38,477
+416% +$4.15M 0.12% 146
2021
Q3
$1.01M Sell
9,246
-6,965
-43% -$763K 0.03% 603
2021
Q2
$1.52M Buy
16,211
+11,557
+248% +$1.08M 0.05% 437
2021
Q1
$428K Sell
4,654
-15,150
-76% -$1.39M 0.02% 826
2020
Q4
$1.45M Buy
+19,804
New +$1.45M 0.05% 294
2020
Q3
Hold
0
1266
2020
Q2
Hold
0
1113
2019
Q2
Sell
-36,227
Closed -$957K 915
2019
Q1
$957K Buy
36,227
+6,227
+21% +$164K 0.09% 182
2018
Q4
$586K Buy
+30,000
New +$586K 0.09% 181